Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis
oleh: Ramya Muddasani, Neel Talwar, Jaime Andres Suarez‐Londono, Marc Braunstein
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2020-05-01 |
Deskripsi
Abstract Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B‐cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in higher risk CLL subgroups.